Loading…

Peer review of the pesticide risk assessment of the active substance Bacillus amyloliquefaciens strain AH2

The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the Netherlands for the pesticide active substance Bacillus amyloliquefaciens strain AH2 are reported. The context of the peer review was that requi...

Full description

Saved in:
Bibliographic Details
Published in:EFSA journal 2020-07, Vol.18 (7), p.e06156-n/a
Main Authors: Anastassiadou, Maria, Arena, Maria, Auteri, Domenica, Brancato, Alba, Bura, Laszlo, Carrasco Cabrera, Luis, Chaideftou, Eugenia, Chiusolo, Arianna, Crivellente, Federica, De Lentdecker, Chloe, Egsmose, Mark, Fait, Gabriella, Greco, Luna, Ippolito, Alessio, Istace, Frederique, Jarrah, Samira, Kardassi, Dimitra, Leuschner, Renata, Lostia, Alfonso, Lythgo, Christopher, Magrans, Oriol, Mangas, Iris, Miron, Ileana, Molnar, Tunde, Padovani, Laura, Parra Morte, Juan Manuel, Pedersen, Ragnor, Reich, Hermine, Santos, Miguel, Serafimova, Rositsa, Sharp, Rachel, Stanek, Alois, Sturma, Juergen, Szentes, Csaba, Terron, Andrea, Tiramani, Manuela, Vagenende, Benedicte, Villamar‐Bouza, Laura
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The conclusions of EFSA following the peer review of the initial risk assessments carried out by the competent authority of the rapporteur Member State the Netherlands for the pesticide active substance Bacillus amyloliquefaciens strain AH2 are reported. The context of the peer review was that required by Regulation (EC) No 1107/2009 of the European Parliament and of the Council. The conclusions were reached on the basis of the evaluation of the representative use of Bacillus amyloliquefaciens AH2 as a fungicide on grapes. The reliable endpoints, appropriate for use in regulatory risk assessment, are presented. Missing information identified as being required by the regulatory framework is listed. Concerns are identified.
ISSN:1831-4732
1831-4732
DOI:10.2903/j.efsa.2020.6156